Immunoassays are a diagnostic procedure carried out in a laboratory to assess the level of several biomolecules such as hormones and proteins, which are indicators of the presence of disorders or conditions such as HIV, autoimmune, diabetes, hepatitis, and thyroid disorders, among others. In the past few decades, there has been a tremendous development in immunodiagnostics. For instance, the use of smartphones for immunodiagnostics is likely to increase the reach of these testing methods to remote locations in several developing countries. Equipped with high-resolution cameras, GPRS, cloud computing technology, and advanced processors, telemedicine is set to be the future of immunodiagnostics. With billions of phone users around the world, the smartphone-based immunodiagnostics segment is expected to establish a firm foothold in the global immunoassay instruments market.
The global immunoassay instruments market is segmented on the basis of products, applications, and geography. The products in the global immunoassay instruments market are multiplexed assay systems, radioimmunoassay analyzers, enzyme linked fluorescent systems, immuno fluorescence (IFA) analyzers, enzyme immunoassay instruments, and chemiluminescence (CLI) analyzers. The application of immunoassay instruments is seen in areas such as cardiology, oncology, endocrinology, for treating infectious diseases, therapeutic drug monitoring, and drugs of abuse. Geographically, this market is spread over Europe, North America, Asia Pacific, and Rest of the World.
Browse Market Research Report of Immunoassay Instruments Market: http://www.transparencymarketresearch.com/immunoassay-instruments-market.html
Chemiluminescence (CLI) Analyzers Segment to Lead Global Immunoassay Instruments Market
The global immunoassay instruments market has been growing at a rapid pace due to increasing technological innovations and the growing number of applications that are in dire need of improved performance. According to industrial analysts, the chemiluminescence (CLI) analyzers segment held the biggest market share in 2013, accounting for 27% of the global immunoassay instruments market. CLI analyzers are expected to continue their dominance in the coming few years as well. IFA and ELFA systems are also expected to show sturdy growth in the forecast period. The wide range of applications of immunoassay instruments is leading to a huge demand for immunoassay instruments, thereby creating a scope for the market’s development.
Browse Market Research Press Release of Immunoassay Instruments Market: http://www.transparencymarketresearch.com/pressrelease/immunoassay-instruments-market.htm
North America and Europe to Emerge as Top Regions in the Global Immunoassay Market
In 2013, North America accounted for the biggest market share in the global immunoassay instruments market, with Europe following closely. This high growth rate and share can be attributed to the increasing adoption of these instruments in the advanced healthcare system of North America. In the light of statistics presented by the World of Health Organization that diabetes is likely to be the seventh leading cause of death by 2030, when the number of diabetics will reach 347 million, immunoassay procedures are expected to witness a huge demand. These instruments are especially required in several procedures that treat obesity, a predominant problem due to sedentary lifestyles.
The RoW and Asia Pacific immunoassay instruments markets are experiencing a lack of momentum due to lack of accessibility to healthcare facilities and poor per capita incomes. However, emerging economies such as Brazil, India, and China are expected to contribute to the growth of this market in the coming few years as these countries are investing in strong healthcare infrastructures.
The key players in the global immunoassay instruments market are Roche Diagnostics, Beckman Coulter, Abbott Laboratories, and bioMerieux. Their innovations and marketing strategies to reach out to a wider population base will be the pivotal factors determining the shape of this market in the coming few years.